EN7-60796-01810
4 vaccinations
1 coded response
26 check-ins
1 free-text entry
1 call case
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 802 / CO
- Registered
- 2020-12-23
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-23
Registered in v-safe
-
2020-12-23
Dose 1 — Pfizer-BioNTech
- 2020-12-23
- 2020-12-28
- 2020-12-29
- 2020-12-30
- 2021-01-06
-
2021-01-12
Dose 2 — Pfizer-BioNTech
- 2021-01-12
-
2021-01-14
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Chills, Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-01-16
- 2021-01-17
- 2021-01-18
- 2021-01-19
- 2021-01-26
- 2021-02-02
- 2021-02-09
- 2021-02-16
- 2021-02-23
- 2021-04-13
- 2021-07-13
-
2021-08-28
Dose 3 — Pfizer-BioNTech
- 2021-09-28
- 2021-10-04
- 2021-10-09
- 2021-11-27
-
2022-02-16
Dose 4 — Moderna
- 2022-02-26
- 2022-02-26
- 2022-04-01
-
2022-05-18
Survey response — 3 months, dose 4MedDRA: COVID-19, Headache, Myalgia, Oropharyngeal pain, Pyrexia, Respiratory tract congestion, Unevaluable event — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professionalFree text: Symptoms: Covid 5/3/22 Myalgias, fever, headache, congestion, sore throat · Healthcare visit (other): Monoclonal antibodyMedDRA releases: 2024-11 · check-in free text available
-
2022-05-18
Report sent to call center — 3 months, dose 4Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr1 call case(s)
- 2022-05-19
-
2022-05-19
Callback requested for07:00PM ET
-
2022-05-19
Call successfulDoes not wish to fill out VAERS report
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-23 | Pfizer-BioNTech | |
| 2 | 2021-01-12 | Pfizer-BioNTech | |
| 3 | 2021-08-28 | Pfizer-BioNTech | No |
| 4 | 2022-02-16 | Moderna | No |
Call center
1 call center case
1 successful
Free text
Release 11 — 3 months, dose 4
Symptoms: Covid 5/3/22 Myalgias, fever, headache, congestion, sore throat
Healthcare visit (other): Monoclonal antibody
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Unevaluable event | · | · | ✓ |
| SD | COVID-19 | · | · | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Myalgia | · | · | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | Pyrexia | · | · | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release